Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav Pathria

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cancer Cell|July 11, 2018
BRN 2 InvadeGaurav Pathria, Ze'ev A Ronai
Cell Metabolism|January 6, 2021
Harnessing the Co-vulnerabilities of Amino Acid-Restricted CancersGaurav Pathria, Ze'ev A Ronai
The Journal of Investigative Dermatology|July 27, 2012
Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathwaysGaurav Pathria, Christine Wagner, Stephan N Wagner
Indian Journal of Dermatology, Venereology and Leprology|January 12, 2010
Comparison of enzyme-linked immunosorbent assay test with immunoblot assay in the diagnosis of pemphigus in Indian patientsSujay Khandpur, Vinod K Sharma, Alpana Sharma, et al.
Mutagenesis|May 16, 2016
Signal Sequence Receptor 2 is required for survival of human melanoma cells as part of an unfolded protein response to endoplasmic reticulum stressBhavuk Garg, Gaurav Pathria, Christine Wagner, et al.
EMBO Reports|February 8, 2021
MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restrictionGaurav Pathria, Sachin Verma, Jun Yin, et al.
The Journal of Investigative Dermatology|January 15, 2016
RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear ExportGaurav Pathria, Bhavuk Garg, Christine Wagner, et al.
Molecular Cancer Therapeutics|February 26, 2021
Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in MelanomaYongmei Feng, Gaurav Pathria, Susanne Heynen-Genel, et al.
Cancer Discovery|September 8, 2023
SHP2: A Pleiotropic Target at the Interface of Cancer and Its MicroenvironmentNicole M Sodir, Gaurav Pathria, Joanne I Adamkewicz, et al.
The Journal of Investigative Dermatology|June 10, 2011
Polo-like kinase 1 is a potential therapeutic target in human melanomaAhmad Jalili, Anna Moser, Mikhail Pashenkov, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancer Cell|July 11, 2018
BRN 2 InvadeGaurav Pathria, Ze'ev A Ronai
Cell Metabolism|January 6, 2021
Harnessing the Co-vulnerabilities of Amino Acid-Restricted CancersGaurav Pathria, Ze'ev A Ronai
The Journal of Investigative Dermatology|July 27, 2012
Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathwaysGaurav Pathria, Christine Wagner, Stephan N Wagner
Indian Journal of Dermatology, Venereology and Leprology|January 12, 2010
Comparison of enzyme-linked immunosorbent assay test with immunoblot assay in the diagnosis of pemphigus in Indian patientsSujay Khandpur, Vinod K Sharma, Alpana Sharma, et al.
Mutagenesis|May 16, 2016
Signal Sequence Receptor 2 is required for survival of human melanoma cells as part of an unfolded protein response to endoplasmic reticulum stressBhavuk Garg, Gaurav Pathria, Christine Wagner, et al.
EMBO Reports|February 8, 2021
MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restrictionGaurav Pathria, Sachin Verma, Jun Yin, et al.
The Journal of Investigative Dermatology|January 15, 2016
RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear ExportGaurav Pathria, Bhavuk Garg, Christine Wagner, et al.
Molecular Cancer Therapeutics|February 26, 2021
Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in MelanomaYongmei Feng, Gaurav Pathria, Susanne Heynen-Genel, et al.
Cancer Discovery|September 8, 2023
SHP2: A Pleiotropic Target at the Interface of Cancer and Its MicroenvironmentNicole M Sodir, Gaurav Pathria, Joanne I Adamkewicz, et al.
The Journal of Investigative Dermatology|June 10, 2011
Polo-like kinase 1 is a potential therapeutic target in human melanomaAhmad Jalili, Anna Moser, Mikhail Pashenkov, et al.
Pageof 2